A detailed history of Baker Ellis Asset Management LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Baker Ellis Asset Management LLC holds 2,328 shares of ABT stock, worth $267,161. This represents 0.04% of its overall portfolio holdings.

Number of Shares
2,328
Holding current value
$267,161
% of portfolio
0.04%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$100.07 - $118.13 $232,962 - $275,006
2,328 New
2,328 $265,000
Q2 2022

Jul 22, 2022

SELL
$102.07 - $123.37 $175,152 - $211,702
-1,716 Closed
0 $0
Q3 2021

Oct 15, 2021

BUY
$116.66 - $129.06 $200,188 - $221,466
1,716 New
1,716 $201,000
Q3 2020

Nov 13, 2020

SELL
$91.64 - $111.29 $119,132 - $144,677
-1,300 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$76.57 - $98.0 $2,297 - $2,940
30 Added 2.36%
1,300 $119,000
Q1 2020

May 12, 2020

SELL
$62.82 - $91.86 $34,551 - $50,523
-550 Reduced 30.22%
1,270 $100,000
Q4 2019

Feb 10, 2020

SELL
$78.51 - $87.4 $1.11 Million - $1.23 Million
-14,090 Reduced 88.56%
1,820 $158,000
Q3 2019

Nov 12, 2019

BUY
$81.84 - $88.74 $41,738 - $45,257
510 Added 3.31%
15,910 $1.33 Million
Q2 2019

Aug 12, 2019

BUY
$72.88 - $85.0 $14,576 - $17,000
200 Added 1.32%
15,400 $1.3 Million
Q2 2018

Aug 14, 2018

SELL
$57.57 - $63.54 $8,059 - $8,895
-140 Reduced 0.91%
15,200 $927,000
Q1 2018

Apr 19, 2018

BUY
$56.27 - $63.62 $7,877 - $8,906
140 Added 0.92%
15,340 $919,000
Q4 2017

Jan 30, 2018

SELL
$53.68 - $57.47 $1.3 Million - $1.39 Million
-24,204 Reduced 61.43%
15,200 $867,000
Q3 2017

Oct 18, 2017

BUY
$48.06 - $53.64 $1.89 Million - $2.11 Million
39,404
39,404 $2.1 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Baker Ellis Asset Management LLC Portfolio

Follow Baker Ellis Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baker Ellis Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baker Ellis Asset Management LLC with notifications on news.